FluoGuide A/S

Headquarters: Copenhagen, Denmark

Employees: 3

show_chart OMX: FLUO +0.45%

Market Cap

kr678.8 Million

SEK as of Jan. 1, 2023

US$65.0 Million

history Market Cap History

FluoGuide A/S market capitalization over time

Evolution of FluoGuide A/S market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of FluoGuide A/S

Detailed Description

FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. It develops FG001, which is in phase I/II for the treatment of high-grade glioma; and FG002 that allows surgeons to differentiate cancer from normal tissue during surgery through a novel urokinase-type plasminogen activator receptor targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was founded in 2018 and is based in Copenhagen, Denmark.

Stocks & Indices

FluoGuide A/S has the following listings and related stock indices.

Stock: OMX: FLUO

Stock: FSX: 96X



Ole Maaløes Vej 3

Copenhagen, 2200


Phone: 45 31 22 66 60